In vitro characterization of TGF-β1 release from genetically modified fibroblasts in Ca2+-alginate microcapsules

ASAIO Journal

Volumn 51, Issue 4, 2005, Pages 379-384

  Paek, Hyun J ^a   Campaner, Anelisa B ^a   Kim, Jennifer L ^a   Aaron, Roy K ^b   Ciombor, Deborah M ^b   Morgan, Jeffrey R ^a   Lysacht, Michael J ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CALCIUM; CARTILAGE; CROSSLINKING; GENETIC ENGINEERING; SOLUTIONS; TISSUE;

FIBROBLASTS; GENE ENCODING; MICROCAPSULES; TRANSFORMING GROWTH FACTOR (TGF);

CELLS;

CALCIUM ALGINATE; CALCIUM CHLORIDE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BIOARTIFICIAL ORGAN; CARTILAGE; CELL SECRETION; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; CROSS LINKING; DNA MODIFICATION; ENCAPSULATION; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; ORTHOPEDICS; PROTEIN SECRETION; PROTEIN SYNTHESIS; TISSUE ENGINEERING;

ALGINATES; ANIMALS; CAPSULES; CELL CULTURE TECHNIQUES; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; FIBROBLASTS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MICE; NIH 3T3 CELLS; RETROVIRIDAE; SKIN; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 23144462248     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000169116.84336.c3     Document Type: Article

References (33)

1. Buckwalter JA, Mankin HJ: Articular cartilage. Part I: Tissue design and chondrocytes-matrix interactions. J Bone Joint Surg Am 79: 600-611, 1997.
2. Freed LE, Vunjak-Novakovic G: Tissue engineering of cartilage, in Bronzino JD (ed), The Biomedical Engineering Handbook. Boca Raton, FL, CRC Press, 2000, pp. 124(1)-124(26).
3. Davis MA, Ettinger WH, Neuhaus JM, et al: The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Am J Epidemiol 130: 278-288, 1989.
4. Fuller JA, Ghadially FN: Ultrastructural observations on surgically produced partial-thickness defects in articular cartilage. Clin Orthop 86: 193-205, 1972.
5. The bone and joint decade: joint motion 2000-2010. Available at: www.boneandjointdecade.org. Accessed on January 15, 2005.
6. Breedveld FC: Osteoarthritis-the impact of a serious disease. Rheumatology 4: i4-i8, 2004.
7. Bone and joint decade: 2002-USA-2011. Available at: www. usbjd.org. Accessed on January 15, 2005.
8. Tubo R. Tissue engineering: restoring wounded knee. Sci Med 6: 6-7, 1999.
9. Lysaght MJ, O'Loughlin JA: Demographic scope and economic magnitude of contemporary organ replacement therapies. ASAIO J 46: 515-521, 2000.
10. Brittberg M, Lindahl A, Nillson A, et al: Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895, 1994.
11. Verbruggen G, Cornelissen M, Almqvist KF, et al: Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes. Osteoarthr Cartil 8: 170-179, 2000.
12. De Groot J, Verzijl N, Bank RA, et al: Age-related decrease in proteoglycan synthesis of human articular chondrocytes: The role of nonenzymatic glycation. Arthritis Rheum 42: 1003-1009, 1999.
13. Bock AK, Ibarreta D, Rodriguez-Cerezo E, et al: Human tissue-engineered products: today's markets and future prospects. Technical Report Series October 2003.
14. Ferguson CM, Schwarz EM, Puzas JE, et al: Transforming growth factor-β1 induced alteration of skeletal morphogenesis in vivo. J Ortho Res 22: 687-696, 2004.
15. Caterson EJ, Li WJ, Nesti LJ, et al: Polymer/alginate amalgam for cartilage tissue engineering. Ann N Y Acad Sci 961: 134-138, 2002.
16. Miura Y, Parvizi J, Fitzsimmons JS, et al: Brief exposure to high-dose transforming growth factor-β1 enhances periosteal chondrogenesis in vitro. J Bone and Joint Surg Am 84: 793-799, 2002.
17. Lee KH, Song SU, Hwang TS, et al: Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor-β1-producing fibroblasts. Hum Gene Ther 12: 1805-1813, 2001.
18. Rosier RN, O'Keefe, RJ, Crabb ID, et al: Transforming growth factor beta: an autocrine regulator of chondrocytes. Connect Tissue Res 20: 295-301, 1989.
19. Redini F, Min W, Demoor-Fossard M, et al: Differential expression of membrane-anchored proteoglycans in rabbit articular chondrocytes cultured in monolayers and in alginate beads: Effect of transforming growth factor-beta1. Biochem Biophys Acta 1355: 20-32, 1997.
20. Redini F, Mauviel A, Pronost S, et al: Transforming growth factor beta exerts opposite effects from interleukin-1 beta on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 36: 44-50, 1993.
21. Aaron RK, Boyan BD, Ciombor DM, et al: Stimulation of growth factor synthesis by electric and electromagnetic fields. Clin Orthop 419: 30-37, 2004.
22. 1 levels by EMF coincident with chondrogenesis: Implications for skeletal repair and tissue engineering. J Orthop Res 20: 233-240, 2002.
23. 1 expression. Bioelectromagnetics 20: 453-458, 1999.
24. O'Loughlin J, Bruder JA, Lysaght MJ: Degradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymes. ASAIO J 50: 253-260, 2004.
25. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908-910, 1980.
26. Lundberg P, Berners-Price SJ, Roy S, et al: NMR studies of erythrocytes immobilized in agarose and alginate gels. Magn Reson Med 210: 273-288, 1980.
27. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, et al: Maintenance of normoglycemia in diabetic mice by SC xenografts of encapsulated islets. Science 254: 1782-1784, 1991.
28. Colton CK: Implantable biohybrid artificial organs. Cell Transplant 4: 415-436, 1995.
29. Tsang ML, Zhou L, Zheng B, et al: Characterization of recombinant soluble human transforming growth factor-β receptor type II. Cytokine 7: 389-397, 1995.
30. Medalie DA, Eming SA, Collins ME, et al: Differences in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts. Transplantation 64: 454-465, 1997.
31. Campaner AB, Ferreira LM, Fillo AG, et al: Upregulation of TGF-β1 expression may be necessary but is not sufficient for excessive scarring. (submitted)
32. Le Doux JM, Landazuri N, Yarmush ML, et al: Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Hum Gene Ther 12: 1611-1621, 2001.
33. Morgan JR, Le Doux JM, Snow RG, et al: Retrovirus infection: Effect of time and target cell number. J Virol 69: 6994-7000, 1995.